Client & Alumni News
With the global COVID-19 pandemic, CEO Stephen Tang and his team at Ben Franklin client OraSure Technologies are facing their biggest challenge yet, creating a test that will accurately and quickly determine if a person has been exposed to the COVID-19 virus.
During a recent press conference, Pennsylvania Health Secretary Dr. Rachel Levine, called the rapid antigen test that OraSure hopes to have FDA approved and to market by year’s end a “game changer.” It would be the first antigen test on the market that wouldn’t need lab equipment or trained professionals to get result and could be easily used at home, the office or in schools.
Such a test could have a dramatic impact on stopping the spread of the disease, saving lives and reopening the economy, Levine said. Via Lehigh Valley Business
